The novel 1-(2-fluorovinyl)-4-quinolone-3-carboxylic acid derivatives Z-15a-c, E-15a-c, Z-16a-c, and E-16a-c, conformationally restricted analogues of fleroxacin (5), were synthesized, and their in vitro antibacterial activity was evaluated. A dehydrosulfenylation of a 2-fluoro-2-[(4-methoxyphenyl)sulfinyl]ethyl group was employed as a key step for the construction of a 2-fluorovinyl group at the N-1 position. It appeared evident that the Z-isomers Z-15a-c and Z-16a-c exhibited 2-to 32-fold more potent in vitro antibacterial activity than the corresponding E-isomers E-15a-c and E-16a-c. Furthermore, since Z-15b showed in vitro antibacterial activity and DNA gyrase inhibition comparable to that of 5, it was hypothesized that the conformation of Z-15b would be equivalent to the active conformer of 5. The results revealed that the antibacterial Z-1-(2-fluorovinyl)quinolone derivatives carry the novel N-1 substituent of the fluoroquinolones.
Introduction
Since the development of norfloxacin (1), 1 the first new quinolone (fluoroquinolone) in which a fluorine atom is attached at the C-6 position, other fluoroquinolones (e.g., ciprofloxacin (2) 2 and levofloxacin (3)) 3 have been developed and clinically used for the treatment of various infectious diseases. A number of syntheses of fluoroquinolone analogues have been reported, together with the corresponding structure-activity relationship (SAR) studies. 4 It is of particular note that the N-1 substituent of fluoroquinolones plays an important role in the antibacterial activity of the fluoroquinolones, and alkyl groups such as ethyl, vinyl, cyclopropyl, and tert-butyl groups have been regarded as suitable N-1 substituents. In addition, the stereochemistry of the N-1 substituent of fluoroquinolones is also known to be important for the antibacterial activity of the fluoroquinolones, as is their bulkiness. For example, in the case of 3, which possesses a rigid N-1 structure restricted by a 1,8-annulated ring system, the 3S-enantiomer of 3 was revealed as having 8-128 times more potent activity than the 3R-enantiomer of 3. 3 Even in the case of 1-(2-fluorocyclopropyl)quinolone derivative 4, the conformation of the N-1 substituent possessing a fluorine atom is restricted by a cyclopropane ring. It has been reported that the cis isomer exhibited more potent antibacterial activity than the trans isomer ( Figure 1 ). 5 These results indicated that the antibacterial potency of fluoroquinolone would be optimized by restricting the conformation of the N-1 substituent within narrow limits. Thus, for the present study, we focused on the 2-fluoroethyl group, the N-1 substituent of fleroxacin (5) 6 (Figure 2 ). We designed and synthesized 1-(2-fluorovinyl)quinolone derivatives 15 and 16 (Figure 2 ), both bearing a 2-fluorovinyl group and the conformation of which is restricted by the introduction of a double bond into a 2-fluoroethyl group of 5. The Z-isomers Z-15a-c and Z-16a-c appeared to exhibit a 2-to 32-fold more potent in vitro antibacterial activity than the corresponding E-isomers E-15a-c and E-16a-c. It was also found that Z-15b, structurally related to 5, showed comparable activity and DNA gyrase inhibition to that of 5; thus, it is possible that the conformation of Z-15b is in fact equivalent to the active conformer of 5.
In this paper, we present the synthesis and in vitro antibacterial activity of the fluoroquinolone derivatives 15 and 16 carrying a Z-or E-(2-fluorovinyl) group as novel N-1 substituents.
Results and Discussion
Chemistry. The synthetic strategy of the 1-(2-fluorovinyl)-7-substituted-4-quinolone-3-carboxylic acid (15, 16 ) is given in Scheme 1. We employed a dehydrosulfenylation of 12, carrying a 2-fluoro-2-[(4-methoxy- phenyl)sulfinyl]ethyl group 7 of 12 as a key step in the construction of the 2-fluorovinyl group at the N-1 position.
The synthesis of 2-fluoro-2-[(4-methoxyphenyl)sulfinyl]ethylamine (9) , used as the starting material, was achieved by hydrazinolysis of the known sulfoxide 8, 8 which was provided from 6 according to slightly modified previously reported procedures. 9 After the treatment of 8 with hydrazine monohydrate, separation of the diastereomers of 9 by column chromatography gave anti isomer 9a and syn isomer 9b. The ratio of 9a to 9b was approximately 7:2. The stereochemistry of 9a and 9b was determined by comparison of 9a and 9b as regards the chemical shifts of the C 1 hydrogen atom in 1 H NMR and the C 1 carbon atom in 13 C NMR. These studies were performed on the basis of the reported results for 1-(phenylsulfenyl)-1-fluoroethane. 10 The major anti isomer 9a was used as the starting material to synthesize 12, which bears a 2-fluoro-2-[(4-methoxyphenyl)sulfinyl]ethyl group at the N-1 position (Scheme 2).
The synthetic route of 6,7-difluoro-1-(2-fluorovinyl)-8-substituted-4-quinolones 13a-c is shown in Scheme 3. Treatment of benzoyl acetates 10a-c 11 with dimethylformamide dimethylacetal 12 followed by reaction with 9a gave enaminoesters 11a-c, respectively. Cyclization of 11a-c under basic conditions afforded the 1-[2-fluoro-2-(4-methoxyphenyl)sulfinyl]ethyl-4-quinolone derivatives 12a-c. Thermal elimination of 4-methoxybenzensulfinic acid from 12a-c in xylene gave the desired 6,7- difluoro-1-(2-fluorovinyl)-8-substituted-4-quinolones 13a-c in a high yield as the mixture of geometrical isomers Z-13a-c and E-13a-c. The ratio of the geometrical isomers Z and E was approximately 1:2, as calculated from the integration value obtained by 1 H NMR. The geometric isomers of 8-fluoro and 8-methoxy derivatives 13b,c were inseparable at this stage by silica gel column chromatography. On the other hand, the geometrical isomers Z-13a and E-13a of the 8-hydrogen derivative 13a were successfully separated by silica gel column chromatography. Their geometries were determined by comparison of the coupling constants between H 1 ′ and F 2 ′, as shown in Figure 3 .
Hydrolysis of ester Z-13a under acidic conditions gave acid Z-14a without geometric isomerization. Reaction of Z-14a with 1-methylpiperazine gave the 7-(4-methylpiperazinyl) derivative Z-15a. Reaction of Z-14a with 3-(tert-butoxycarbonylamino)pyrrolidine, followed by removal of a tert-butoxycarbonyl (Boc) group, gave the 7-(3-aminopyrrolidinyl) derivative Z-16a as its hydrochloride. The geometric isomers E-15a and -16a were synthesized from E-13a in the same manner as described for Z-15a and -16a. The geometrical isomers of 13b and 13c were converted to the corresponding acids 14b and 14c in the same manner as described for the synthesis of 14a. Reaction of 14b and 14c with 1-methylpiperazine followed by separation of the geometric isomers gave the 7-(4-methylpiperazinyl) derivatives Zand E-15b, and Z-and E-15c, respectively. Reaction of 14b and 14c with 3-Boc-aminopyrrolidine, separation of the geometrical isomers, and subsequent deprotection of the Boc groups furnished the 7-(3-aminopyrrolidinyl) derivatives Z-and E-16b, and Z-and E-16c, respectively.
Antibacterial Activity. The in vitro antibacterial activity of the Z-and E-1-(2-fluorovinyl)quinolone derivatives (15 and 16) against two Gram-positive strains (Staphylococcus aureus Smith and Streptococcus pneumoniae type III) and against two Gram-negative strains (Escherichia coli NIHJ JC-2 and Pseudomonas aeruginosa IID 1210) are shown in Table 1 exhibited 2-to 32-fold more potent in vitro antibacterial activity against both of the Gram-positive and both of the Gram-negative strains than did the corresponding E-isomers E-15a-c and E-16a-c. Our findings match the case of 1-(2-fluorocyclopropyl)quinolone derivatives, of which the cis isomers exhibited more potent antibacterial activity than the trans isomers. 5 In addition, Z-15a-c and Z-16a-c exhibited comparable in vitro antibacterial activity to that of 5. Among the compounds tested, the 7-(3-aminopyrrolidinyl) derivative Z-16b, which bears a fluorine atom at the C-8 position, exhibited the most potent in vitro antibacterial activity of all of the compounds, and Z-16b showed comparable in vitro antibacterial activity against S. aureus Smith, St. pneumoniae type III, and P. aeruginosa IID1210 to that of 2, with the exception of its activity against E. coli NIHJ JC-2.
Next, we evaluated the inhibition potencies of Z-15b and E-15b, which are conformationally restricted analogues of 5, and the inhibition potentials of 2 and 5 in the presence of DNA gyrase of S. aureus. As shown in Table 2 , the IC 50 value of Z-15b was 9-fold smaller than that of E-15b and was comparable to that of 5. This difference in the inhibition abilities of Z-15b, E-15b, and 5 reflected the differences in the in vitro antibacterial activity of those compounds against S. aureus Smith. The stereochemistry of the 2-fluorovinyl group, or the position of the fluorine atom of the 2-fluorovinyl group of Z-15a and E-15b, appeared to exert an influence on both in vitro antibacterial activity and inhibition of the target enzyme, DNA gyrase.
Conformation Analysis. Since Z-15b exhibited equal ability to inhibit the target enzyme, DNA gyrase, and also because it was revealed to have comparable in vitro antibacterial activity to that of 5, Z-15b could be regarded as an active conformer of 5. Therefore, we performed a study to determine the active conformer of 5 by defining the conformation of the 1-(2-fluorovinyl) group. First, to confirm the position of the fluorine atom on the 1-(2-fluorovinyl) group, we carried out NOE experiments using 1 H NMR analysis of the 8-hydrogen derivatives Z-15a and E-15a. The results are shown in Figure 4 . The NOEs were observed between H 1 ′ and both H 2 and H 8 for both Z-15a and E-15a. From these NOE data, it became apparent that the 2-fluorovinyl groups of Z-15a and E-15a are oriented above (or below) the plane of the quinolone ring. Furthermore, the NOE was also observed between H 2 ′ and H 2 for E-15a; longrange coupling ( 5 J ) 1.0 Hz) with F 2 ′ was also observed in H 2 for Z-15a. These 1 H NMR data indicated that the fluorine atoms on the 2-fluorovinyl groups of Z-15a and E-15a existed on the side opposing H 8 .
Additional NOE experiments were performed using the 8-fluoro derivatives Z-15b and E-15b, which are conformationally restricted analogues of 5. The NOEs were observed between H 1 ′ and H 2 for both Z-15b and E-15b and between H 2 ′and H 2 for E-15b, as shown in Figure 5 . In addition, long-range coupling ( 5 J ) 1.5 Hz) with F 2 ′ was observed in H 2 for Z-15b. These 1 H NMR results of Z-15b and E-15a were similar to those of the corresponding 8-hydrogen derivatives Z-15a and E-15a. It was therefore indicated that the 2-fluorovinyl groups of Z-15b and E-15b have conformations similar to those of Z-15a and E-15a, respectively.
To define the active conformer of 5, we then carried out the molecular modeling of the 2-fluorovinyl group of Z-15b. The dihedral angle of C 2 -N 1 -C 1 ′-C 2 ′ (denoted as Θ in this paper) of Z-15b and that of 5 changed from -180°to 180°by increments of 5°, and the energy of each conformer was calculated by using AM1 parameters. The results are given in Figure 6 . In the case of Z-15b, it appeared that the two energy minima conformers existed. One of these conformers was energy minimum conformer located above the plane of the quinolone ring and was on the opposite side of a C 8 -fluorine atom (Θ ) 45°, conformer A), and the other was located under the plane of the quinolone ring (Θ ) -45°, conformer B). There was very little energy difference (0.195 kcal/mol) between the two. These results were in good agreement with the results of the 1 H NMR experiments with Z-15b. In contrast, in the case of 5, although there existed the one energy minimum conformer and it was located under the plane of the quinolone ring (Θ ) -85°, conformer C), there was no energy minimum conformer above the plane of the quinolone ring. These calculation results showed that the conformation of the 2-fluorovinyl group of Z-15b is more restricted than that of the 2-fluoroethyl group of 5, especially within the range of the upper side of the quinolone ring. Furthermore, according to a previous study, which focused on the relationship between the dihedral angle Θ of N1 substituents of fluoroquinolone derivatives using molecular orbital calculation and the in vitro antibacterial activity of this group, it appeared that the active conformer of the N 1 substituents of the fluoroquinolones was located above the plane of the quinolone ring. 13 Consequently, conformer A of Z-15b could be regarded as the active conformer of Z-15b.
On the basis of the results of the conformation analysis of the 2-fluorovinyl group of Z-15b as described above, it is likely that conformer A would be equivalent to the active conformer of 5.
Conclusions
As described above, we succeeded in the design, synthesis, and evaluation of in vitro antibacterial activity on the 4-quinolone-3-carboxylic acids Z-15a-c, E-15a-c, Z-16a-c, and E-16a-c, which are conformationally restricted analogues of 5 carrying a 2-fluoroethyl group as the novel N-1 substituent. The synthesis of these compounds was achieved in five steps from 10a-c by a method featuring a dehydrosulfenylation of the 2-fluoro-2-[(4-methoxyphenyl)sulfinyl]ethyl group as the key step for the construction of the 2-fluorovinyl group at the N-1 position. It appeared evident that the Z-isomers Z-15a-c and Z-16a-c exhibited 2-to 32-fold more potent in vitro antibacterial activity than the corresponding E-isomers E-15a-c and E-16a-c. On the basis of the in vitro antibacterial activity analysis, as well as analysis of the DNA gyrase inhibitory ability of Z-15b and 5, and the conformation analysis of Z-15b, it can be concluded that the conformation of Z-15b is most likely equivalent to the active conformer of 5. Considering the results of the present study, the novel Z-1-(2-fluorovinyl)-4-quinolone-3-carboxylic acid would be an intriguing scaffold for the exploration of novel quinolone antibacterials. Further investigation of the Z-(1-fluorovinyl)quinolones is in progress.
Experimental Section
Melting points were determined with a Yanagimoto micromelting point apparatus and are uncorrected. Elemental analyses are within (0.4% of the theoretical values and were determined by a Yanaco CHN MT-5 instrument. Infrared spectra (IR) were recorded with a JASCO FTIR-5300 spectrometer. Measurements of mass spectra (MS) and highresolution MS (HRMS) were performed with a JEOL JMS SX-102A mass spectrometer. Proton nuclear magnetic resonance ( 1 H NMR) were measured with a JEOL EX-90 (90 MHz) or a JEOL JMN-EX400 (400 MHz) spectrometer. The chemical shifts are expressed in parts per million (δ value) downfield from tetramethylsilane, using tetramethylsilane (δ ) 0) and/ or residual solvents such as chloroform (δ ) 7.26) as an internal standard. Splitting patterns are indicated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad peak. Column chromatography was carried out with silica gel [silica gel 60 (Kanto)] as an absorbent. Merck precoated thin-layer chromatography (TLC) plates (silica gel 60 F 254, 0.25 mm, Art 5715) were used for the TLC analysis. Solutions were dried over sodium sulfate, and the solvent was removed by rotary evaporation under reduced pressure.
N-[2-[2-Fluoro-(4-methoxyphenyl)thio]ethyl]phthalimide (7). Diethylaminosulfur trifluoride (4.21 mL, 31.9 mmol) was added to a solution of N-[2-[(4-methoxyphenyl)sulfinyl]-
ethyl]phthalimide (6, 6.00 g, 18.2 mmol) and antiomonyl(III) chloride (125 mg, 0.548 mmol) in anhydrous CH 2Cl2 (42 mL) under ice cooling, and the mixture was stirred at room temperature for 3 h. After the reaction was quenched by adding saturated aqueous NaHCO 3 solution (36 mL) under ice cooling, the mixture was extracted with CH2Cl2 (50 mL). The combined CH2Cl2 extracts were washed with water (2 × 30 mL), dried over anhydrous Na2SO4, filtered, and then concentrated in vacuo to give 7 (5.52 g, 91%) as pale-brown crystals. To a solution of 7 (5.51 g, 16.6 mmol) in CHCl 3 (100 mL), m-chloroperoxybenzoic acid (65%, 4.41 g, 16.6 mmol) was added at -50 to -40°C for 40 min, and the mixture was stirred at the same temperature for 20 min. The reaction mixture was washed with saturated aqueous NaHCO3 solution (2 × 100 mL), 10% aqueous Na2SO3 (2 × 100 mL) solution and water (100 mL), dried over anhydrous Na2SO4, filtered, and then concentrated in vacuo. Flash chromatography (hexane/AcOEt ) 1:1 f AcOEt) of the residue gave 8 (5.18 g, 90%) as a white solid. 1 1-(2,4,5-trifluorobenzoyl)]acrylate (11a) . To a solution of 10a (1.03 g, 4.18 mmol) in benzene (25 mL), N,Ndimethylformamide dimethyl acetal (2.50 mL, 18.8 mmol) was added. The mixture was heated under reflux for 1 h and then concentrated in vacuo. To a solution of the residue in toluene (12 mL), 9a (1.00 g, 4.60 mmol) was added. The mixture was stirred at room temperature for 2 h and then concentrated in vacuo. Flash chromatography (hexane/AcOEt ) 1:1) of the residue gave 11a (1.57 g, 79%) as a yellow foam. 1 
Ethyl 2-[2-(Fluoro-2-(4-methoxyphenylsulfinyl)ethylamino)-1-(2,3,4,5-tetrafluorobenzoyl)]acrylate (11b).
The compound 11b (1.82 g, 99%) was prepared from 10b (1.00 g, 3.79 mmol) and 9a (948 mg, 4.36 mmol) by the same method as that used for 11a. 1 
Ethyl 2-[2-(Fluoro-2-(4-methoxyphenylsulfinyl)ethylamino)-1-(2,4,5-trifluoro-3-methoxybenzoyl)]acrylate (11c).
The compound 11c (1.62 g, 89%) was prepared from 10c (1.00 g, 3.62 mmol) and 9a (905 mg, 4.17 mmol) by the same method as that used for 11a. 1 
Ethyl 1-[2-Fluoro-2-(4-methoxyphenylsulfinyl)ethyl]-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate (12a).
A solution of 11a (1.28 g, 2.70 mmol) in anhydrous THF (13 mL) was added to a suspension of sodium hydride (60% oil suspension, 108 mg, 2.70 mmol) in anhydrous THF (13 mL) under cooling with ice. After the reaction mixture was stirred at a constant temperature for 30 min, it was poured into ice/ water (30 mL). The resulting precipitates were collected by filtration, washed with water, and then dried in vacuo to give 12a (945 mg, 77% Ethyl 1-[2-Fluoro-2-(4-methoxyphenylsulfinyl)ethyl]-6,7,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylate (12b) . The compound 12b (1.36 g, 80%) was prepared from 11b (1.77 g, 3.75 mmol) by the same method as that used for 12a. Mp: 136-137°C. 1 6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylate (12c). The compound 12c (1.33 g, 88%) was prepared from 11c (1.57 g, 3.12 mmol) by the same method as that used for 12a. Mp Z-14a) . A mixture of Z-13a (273 mg, 1.01 mmol), concentrated H2SO4 (0.7 mL), AcOH (3.5 mL), and water (3.5 mL) was stirred at 100°C for 1 h and then poured into ice/water. The resulting precipitates were collected , and MeCN (2 mL) was heated under reflux for 1 h and concentrated in vacuo. After dilution of the residue with CH 2Cl2 (20 mL), the mixture was successively washed with water (5 mL), aqueous 10% citric acid solution (2 × 5 mL), and water (5 mL). The mixture was then dried over anhydrous Na 2SO4 and concentrated in vacuo. The residue was suspended in saturated HCl in AcOEt solution (2 mL), and the mixture was allowed to stand at room temperature for 30 min. The resulting precipitates were collected by filtration, washed with AcOEt, and then dried in vacuo to give Z-16a (76 mg, 92%) as yellow crystals. Mp: 263-270°C. 1 , and MeCN (5 mL) was heated under reflux for 1 h and then concentrated in vacuo. The residue was dissolved in CH 2Cl2 (5 mL) and successively washed with water (2 mL), aqueous 10% citric acid solution (2 × 2 mL), and water (2 mL). The mixture was then dried over anhydrous Na2SO4 and concentrated in vacuo. Flash chromatography (CH2Cl2/AcOEt ) 1:1) of the residue gave the Z-Boc-amino derivative of Z-16b (72 mg, 23%) as a yellow solid and the E-Boc-amino derivative of E-16b (174 mg, 55%) as a yellow solid. A suspension of the Z-Boc derivative (53 mg, 0.118 mmol) in saturated HCl in AcOEt solution (1 mL) was stirred at room temperature for 1 h and then concentrated in vacuo. After MeOH (2 mL) was added to the residue, the resulting precipitates were collected by filtration, washed with MeOH, and then dried in vacuo to give Z-16b (24 mg, 53%) as yellow crystals. Following the same procedure, the E-Boc-amino derivative (151 mg, 0.333 mmol) was converted to E-16b (89 mg, 69%), giving a yellow powder.
Z-16b. Mp: 240-244°C. 1 In Vitro Antibacterial Activity. The MIC (µg/mL) was determined by the agar dilution method 14 using MullerHinton agar (Difco Laboratories, Detroit, MI). The MIC was defined as the lowest concentration of an antibacterial agent that inhibited visible growth after incubation at 35°C for 18 h.
Inhibitory Activity against DNA Gyrase of S. aureus. The supercoiling activity of DNA gyrase was determined by a previously reported procedure. 15 The inhibitory activity was assayed by determining the concentration required to inhibit 50% of the enzyme reaction.
